Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ann Surg Oncol. 2021 Aug;28(8):4360-4370. doi: 10.1245/s10434-020-09567-3. Epub 2021 Jan 19.
This study aimed to explore the prognostic impact that the log odds of positive lymph nodes (LODDS) has on medullary thyroid cancer (MTC) and to develop a nomogram incorporating LODDS to predict the cancer-specific survival (CSS) of MTC.
Data from 1110 MTC patients after total thyroidectomy were collected from the Surveillance, Epidemiology, and End Results (SEER) database and divided into training and validation cohorts. The prognostic efficiency of N status from the American Joint Committee on Cancer (AJCC) staging system, the number of positive lymph nodes (PLNN), and LODDS were compared using the Harrell concordance index (C-index), the Akaike information criterion (AIC), and area under the receiver operating characteristic (ROC) curve (AUC). A multivariate Cox analysis was performed to determine the independent prognostic factors, and a nomogram based on LODDS was constructed. The nomogram's performance was assessed with the C-index, AUC, calibration curves, and decision curve analysis (DCA).
Among the three lymph node (LN) staging systems, LODDS showed the highest accuracy in predicting CSS for MTC. In the training cohort, the C-index of the LODDS-based nomogram was 0.895. The AUCs were 0.949, 0.917, 0.925, and 0.901 for predicting 1-, 3-, 5- and 10-year CSS, respectively. The calibration plots and DCA showed the superior clinical applicability of the nomogram. These results were verified in the validation cohort.
As an independent prognostic factor for MTC, LODDS demonstrated superior prognostic efficiency over N status and PLNN. This LODDS-based nomogram yielded better performance than the AJCC tumor-node-metastasis (TNM) staging system in predicting CSS after surgery for MTC.
本研究旨在探讨淋巴结阳性对数 odds(LODDS)对髓样甲状腺癌(MTC)的预后影响,并开发一个纳入 LODDS 的列线图来预测 MTC 的癌症特异性生存(CSS)。
从监测、流行病学和最终结果(SEER)数据库中收集了 1110 例接受全甲状腺切除术的 MTC 患者的数据,并将其分为训练和验证队列。使用 Harrell 一致性指数(C-index)、Akaike 信息准则(AIC)和接受者操作特征(ROC)曲线下面积(AUC)比较了美国癌症联合委员会(AJCC)分期系统的 N 分期、阳性淋巴结(PLNN)数量和 LODDS 的预后效率。采用多变量 Cox 分析确定独立的预后因素,并构建了基于 LODDS 的列线图。通过 C-index、AUC、校准曲线和决策曲线分析(DCA)评估了列线图的性能。
在三种淋巴结(LN)分期系统中,LODDS 对预测 MTC 的 CSS 最准确。在训练队列中,基于 LODDS 的列线图的 C-index 为 0.895。AUC 分别为 0.949、0.917、0.925 和 0.901,用于预测 1、3、5 和 10 年 CSS。校准图和 DCA 显示了该列线图具有优越的临床适用性。这些结果在验证队列中得到了验证。
作为 MTC 的独立预后因素,LODDS 在预测 MTC 术后 CSS 方面优于 N 分期和 PLNN。与 AJCC 肿瘤-淋巴结-转移(TNM)分期系统相比,基于 LODDS 的列线图在预测 MTC 术后 CSS 方面具有更好的性能。